Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.

CompletedOBSERVATIONAL
Enrollment

298

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

March 3, 2023

Study Completion Date

March 3, 2023

Conditions
Advanced Chronic Liver Disease, NASH
Interventions
DEVICE

VCTE with splenic stiffness measurement

Subjects will undergo vibration controlled transient elastography to measure liver stiffness (LSM) liver steatosis via controlled attenuation parameter (CAP) and splenic stiffness

Trial Locations (1)

46202

Indiana University School of Medicine, Indianapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Echosens

INDUSTRY

lead

Indiana University

OTHER

NCT03778411 - Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan. | Biotech Hunter | Biotech Hunter